Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis

Preclinical studies have shown benefit of apolipoprotein A-I (apoA-I)/high-density lipoprotein (HDL) raising in atherosclerosis; however, this has not yet translated into a successful clinical therapy. Our studies demonstrate that apoA-I raising is more effective at reducing early-stage atherosclero...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Jamie, Bao, Shisan, Vanags, Laura Z., Tsatralis, Tania, Ridiandries, Anisyah, Siu, Chung-Wah, Ng, Kwong-Man, Tan, Joanne T.M., Celermajer, David S., Ng, Martin K.C., Bursill, Christina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059906/
https://www.ncbi.nlm.nih.gov/pubmed/30062204
http://dx.doi.org/10.1016/j.jacbts.2017.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059906/
https://www.ncbi.nlm.nih.gov/pubmed/30062204
http://dx.doi.org/10.1016/j.jacbts.2017.11.004

Ejemplares similares